A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment

NCT05828511 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
149
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Regeneron Pharmaceuticals